DENTSPLY SIRONA(XRAY)
Search documents
Dentsply International (XRAY) Q3 Earnings and Revenues Beat Estimates
ZACKS· 2024-11-07 13:20
Dentsply International (XRAY) came out with quarterly earnings of $0.50 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.49 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 4.17%. A quarter ago, it was expected that this dental products manufacturer would post earnings of $0.50 per share when it actually produced earnings of $0.49, delivering a surprise of -2%.Over the last fou ...
DENTSPLY SIRONA(XRAY) - 2024 Q3 - Quarterly Results
2024-11-07 12:38
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 October 24, 2024 Date of Report (Date of earliest event reported) DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 0-16211 39-1434669 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 13320 Ballantyne Corporate Place, Charlotte North ...
Dentsply Sirona Reports Third Quarter 2024 Results
GlobeNewswire News Room· 2024-11-07 11:00
Net sales of $951 million increased 0.5%, organic sales increased 1.3%GAAP gross margin of 52.1%, GAAP net loss of ($494) million or loss per share of ($2.46)Adjusted EBITDA margin of 17.9%, adjusted EPS of $0.50Revised FY24 outlook: expect organic sales of (3.5%) to (2.5%) (previously (1%) to flat); adjusted EPS of $1.82 to $1.86 (previously $1.96 to $2.02) CHARLOTTE, N.C., Nov. 07, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its financi ...
Should You Buy, Sell or Hold DENTSPLY SIRONA Before Q3 Earnings?
ZACKS· 2024-11-05 13:56
DENTSPLY SIRONA Inc. (XRAY) is scheduled to release third-quarter 2024 results on Nov. 7, before the opening bell.In the last reported quarter, the company’s earnings missed the Zacks Consensus Estimate. It delivered an average earnings surprise of 0.6% in the past four quarters. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Q3 EstimatesThe Zacks Consensus Estimate for revenues is pegged at $940.6 million. The consensus mark for earnings is pinned at 48 cents per share.Factors to ...
Dentsply Sirona Shares Fall After Suspension of Byte Aligner Products
ZACKS· 2024-10-28 15:30
Dentsply Sirona, Inc. (XRAY) has voluntarily suspended sales and marketing of its Byte Aligners and Impression Kits as part of a regulatory review with the FDA. During this suspension, shipments and new orders have been paused to assess compliance standards. The company aims to ensure strict adherence to quality and safety protocols, working closely with regulatory bodies and communicating with healthcare providers to maintain patient care. XRAY Stock Movement Following the News Following the news, shares o ...
Dentsply Sirona to Host Conference Call Regarding Update on Byte Aligner Products
GlobeNewswire News Room· 2024-10-25 11:00
CHARLOTTE, N.C., Oct. 25, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced it will host a conference call to discuss its Byte Aligner business. Dentsply Sirona’s management team will host an investor conference call and live webcast on October 25, 2024, at 9:00 am ET. For those planning to participate on the call, please register at https://register.vevent.com/register/BI91fb506c8c2944bca6e65629062dd357. A webcast replay of the conference call ...
Dentsply Sirona Provides Update on Byte Aligner Products
GlobeNewswire News Room· 2024-10-24 21:26
Voluntarily Suspends Sales and Marketing of Byte Aligners and Impression Kits Provides Select Preliminary Third Quarter 2024 Results CHARLOTTE, N.C., Oct. 24, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY), today announced the voluntary suspension of sales and marketing of its Byte Aligners and Impression Kits while the Company conducts a review of certain regulatory requirements related to these products. The Company’s decision was made in consultation wit ...
Dentsply Sirona Sustainability Report 2023: Year of continued action leads to strong results and several goals achieved ahead of time
Prnewswire· 2024-10-15 12:00
The report shows strong overall progress against its goals for the fourth year in a row as well as several goals met ahead of their 2025 timeframe. Guided by its sustainability strategy "BEYOND: Taking Action for a Brighter World", Dentsply Sirona has achieved positive impact along its three pillars: Healthy Planet (environmental goals), Healthy Smiles (social goals) and Healthy Business (governance goals). Highlights from the 2023 Sustainability Report include but are not limited to: Significant reduction ...
Dentsply Sirona to Host Third Quarter Conference Call on November 7th
GlobeNewswire News Room· 2024-10-09 10:00
CHARLOTTE, N.C., Oct. 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, November 7, 2024, at 8:30 am ET to review its third quarter financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. Conference Call / Webcast Information A live webcast will b ...
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now
ZACKS· 2024-09-30 12:55
DENTSPLY SIRONA (XRAY) is well-poised for growth on a robust product portfolio and continued focus on research and development. However, forex remains a concern. Shares of this Zacks Rank #3 (Hold) company have lost 24% year to date against the industry's 0.3% growth. The S&P 500 Index has gained 20.5% in the same time frame. XRAY, with a market capitalization of $5.41 billion, is a global leader in the design, development, manufacturing and marketing of dental consumables, dental laboratory products, denta ...